Intravenous ferric carboxymaltose versus oral ferrous sulphate for the treatment of moderate-to-severe postpartum anaemia in Nigerian women (IVON-PP): an open-label, randomised controlled trial - PubM
4 hours ago
- #postpartum anaemia
- #iron therapy
- #randomized controlled trial
- Study compares intravenous ferric carboxymaltose vs. oral ferrous sulphate for postpartum anaemia in Nigerian women.
- Randomized controlled trial with 1400 participants, showing ferric carboxymaltose more effective (18% vs. 32% anaemia prevalence at 6 weeks).
- Ferric carboxymaltose had fewer adverse events (8%) compared to ferrous sulphate (20%).
- Primary outcome was anaemia prevalence at 6 weeks postpartum, analyzed by intention to treat.
- Study funded by Bill & Melinda Gates Foundation, published under CC BY 4.0 license.